Inactive Instrument

Insiders EXOPHARM

Equities

Exopharm to Cut CEO Role Amid Cost Reductions	Nov. 28	MT
Exopharm Limited Announces Ian Dixon's Employment as CEO Expects to End in Early Calendar Year 2024	Nov. 27	CI
Exopharm Limited Announces Executive Changes	23-06-21	CI
Exopharm Limited Announces Board Changes	23-02-22	CI
Exopharm Limited Announces Resignation of Elizabeth McGregor as Non-Executive Director	22-12-20	CI
Exopharm Limited Appoints David Franks as Company Secretary	21-09-30	CI
Exopharm Limited Appoints Jennifer King to the Board, Effective 1 September 2021	21-08-30	CI
Exopharm Limited Announces Board Changes, Effective 5 January 2021	21-01-04	CI
Exopharm Limited Appoints Alison Mew as Interim Director of Manufacturing and Development	20-09-14	CI
Exopharm Limited Announces Management Changes	20-06-15	CI
Exopharm Limited Appoints Christopher Baldwin as Chief Commercial Officer	19-10-27	CI

No results for this search